Myelodysplastic Syndrome Diagnosis and Treatment in Zone 15
Did a routine blood count show unexplained cytopenias, or were you told you might have myelodysplastic syndrome? With Dr. Fabiola Valvert you'll find a complete evaluation, an accurate diagnosis, and a management plan based on your risk level, backed by more than 15 years of experience in bone marrow disorders. Available in person or by video call.
Open for Scheduling
Next available date
this week
Recognized by
American Society of Hematology
Bonanova Health
Harvard & Stanford
Asociación Guatemalteca de Oncología
GELL
What makes this consultation different
Differential diagnosis from other causes of cytopenia
We distinguish MDS from anemia, nutritional deficiencies, and other causes before defining a plan.
Precise risk stratification
The risk level determines whether management is watchful waiting or active treatment — not every case is the same.
Second opinion on your risk classification
We review whether the assigned risk category matches your current test results.
In person or by video call
The same quality of care, wherever you are.
Is this consultation right for you?
Signs that warrant an evaluation:
Persistent fatigue from anemia that doesn't improve
When anemia doesn't respond to iron or the usual causes, and appears alongside other low values on a blood count, it warrants a bone marrow evaluation.
Frequent infections from low white blood cells
When the count of healthy white blood cells is low (neutropenia), the body becomes more exposed to repeated infections.
Bruising or bleeding from low platelets
A low platelet count can go unnoticed until easy bruising or bleeding that takes a long time to stop appears.
An incidental finding on a routine exam
Many MDS cases are detected before causing symptoms, simply because a routine blood count showed something unexpected.
A practice built over time, one patient at a time.
Close, attentive care, with the rigor of the best Hematology practice.
Dr. Fabiola Valvert Gamboa is a Hematologist with a subspecialty in Bone Marrow Transplant. She practices in Guatemala, trained at Europe's leading oncohematology centers, and collaborates on scientific research with some of the most prestigious hospitals in the United States and Latin America. With more than 15 years dedicated to the care of patients with blood cancers, she now leads the Hematology Service at Hospital Bonanova in Zone 15, Guatemala City.
Risk classification in myelodysplastic syndromes
MDS isn't managed the same way in every case — management depends on the risk category, determined by the percentage of immature cells (blasts) in the bone marrow, among other factors. It's distinct from acute myeloid leukemia, though some high-risk MDS cases can progress to it over time.
Low-Risk MDS
Management usually focuses on treating symptoms — such as anemia — with close monitoring, without the need for immediate intensive treatment.
Intermediate-Risk MDS
Requires more frequent evaluation and, in some cases, treatment aimed at controlling the disease before it progresses.
High-Risk MDS
Has a higher chance of progressing to acute myeloid leukemia, so treatment tends to be more active, and in selected cases, bone marrow transplant is considered.
Relationship to Acute Myeloid Leukemia
MDS and AML share an origin in the bone marrow, but are distinguished by the proportion of immature cells present. A precise evaluation determines which diagnosis applies to your case.
What people ask us most before their first appointment.
Can't find your answer? Message us on WhatsApp and we'll respond within business days.
Serving You in Guatemala
Dra. Fabiola Valvert - Hematóloga
Address
15 Avenida 5-50 zona 15 Vista Hermosa 3, Edificio Spazio, Oficina 10-01, Guatemala, Guatemala
Consultation Hours
An abnormal blood count deserves a complete explanation
Message us on WhatsApp and a team member will respond personally to coordinate your appointment.
loading...